Stacked layers showing 3 Bioloupe advantages

Powering Smarter Biopharma Decisions

AI-powered biopharma intelligence & strategy – consulting backed by proprietary data & analytics

AI-powered biopharma intelligence & strategy consulting backed by proprietary data & analytics

Identify
The Data Foundation for Smarter Strategic Decisions

Unique, structured data generated by a proprietary blend of advanced AI and expert manual curation—enabling fast discovery of assets, targets, technologies

Evaluate
Transforming Data into Market Insights

Rapid forecasting, trend analysis, and predictive insights—powered by deeply structured oncology data designed for competitive and strategic evaluation.

Strategize
Translating Insights to Actionable Commercial Strategy

Actionable strategy driven by proprietary data and a senior team with deep expertise in oncology development, commercialization, and business development.

How Bioloupe Can Help You

Whether you're scouting new therapeutic areas, building an investor-ready TPP, or evaluating an asset’s commercial potential, Bioloupe gives you the tools and insights to move faster and decide smarter.

Rapidly Understand New Therapeutic or Technology Areas

Explore curated landscapes of assets, targets, and trials—filterable by modality, mechanism, and stage—to spot trends, gaps, and opportunities.

Make Confident Go/No Go Decisions

Leverage epidemiology, development pipelines, and SoC data—alongside analytics that show how your asset stacks up and what drives success.

Build Strong, Investor-Ready Target Product Profiles

Benchmark against current and future standards of care. Model clinical scenarios and forecast commercial value using our expert tools and structured data.

Connect Data, Strategy, and Execution in One Platform

Break down silos across R&D, commercial, and strategy teams with an integrated platform built to align insights, decisions, and action.

Quickly Assess Sales Potential Without Internal Expertise

Use our prepopulated forecast models, evidence-backed assumptions, and integrated simulations to evaluate asset value—without needing a full commercial team.

Bioloupe: a unique fusion of data, tools, and expertise

Data / Intelligence Providers

Data
Broad, semi-structured data
Lack important data sources
Not manually organized / curated
Tools
Minimal or no analytical tools (data not built for analysis)
Expertise
No therapeutic area and/or commercial expertise

Consulting Firms

Data
Usually do not provide proprietary data
Tools
Tools not offered or need to be custom built
Expertise
Broad, semi-structured data
May lack therapeutic area or operational experience

Bioloupe

Data
Deep, structured, and curated Oncology/Hematology data
All data in one place for fast insights and decision-making
Tools
Built-in tools powered by curated data
Opportunity for customization and data integration
Expertise
Oncology/Heme experts with operational experience
Built by former Pharma leaders
Fast answers, fast recommendations, real-time insights

Looking to make data-driven decisions in biopharma?

Let’s explore how Bioloupe can empower your strategy.